FDA encourages recovered patients to donate plasma for development of blood-related therapies
- Details
- Category: FDA

FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
- Details
- Category: FDA

FDA Continues to Accelerate Development of Novel Therapies for COVID-19
- Details
- Category: FDA

The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients
- Details
- Category: FDA

FDA continues to facilitate development of COVID-19 treatments
- Details
- Category: FDA

FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19
- Details
- Category: FDA

FDA approves new treatment for adults with Cushing's disease
- Details
- Category: FDA

More Pharma News ...
- FDA approves first generic of Daraprim
- FDA takes action with Indian Government to protect consumers from illicit medical products
- FDA approves first drug for treatment of peanut allergy for children
- FDA continues strong support of innovation in development of gene therapy products
- FDA approves first treatment option specifically for patients with epithelioid sarcoma
- FDA approves first treatment for thyroid eye disease
- FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors